Følg
Bendix Carstensen
Bendix Carstensen
Senior Statistician, Steno DIabetes Center Copenhagen
Bekræftet mail på bxc.dk - Startside
Titel
Citeret af
Citeret af
År
Age–period–cohort models for the Lexis diagram
B Carstensen
Statistics in medicine 26 (15), 3018-3045, 2007
5092007
Incidence trends of adenocarcinoma of the cervix in 13 European countries
F Bray, B Carstensen, H Møller, M Zappa, MP Zˇakelj, G Lawrence, ...
Cancer Epidemiology Biomarkers & Prevention 14 (9), 2191-2199, 2005
4542005
Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial
P Gæde, J Oellgaard, B Carstensen, P Rossing, H Lund-Andersen, ...
Diabetologia 59 (11), 2298-2307, 2016
4532016
A Danish diabetes risk score for targeted screening: the Inter99 study
C GLumer, B Carstensen, A Sandbæk, T Lauritzen, T Jørgensen, ...
Diabetes care 27 (3), 727-733, 2004
4272004
Cardiovascular events associated with SGLT-2 inhibitors versus other glucose-lowering drugs: the CVD-REAL 2 study
M Kosiborod, CSP Lam, S Kohsaka, DJ Kim, A Karasik, J Shaw, N Tangri, ...
Journal of the American College of Cardiology 71 (23), 2628-2639, 2018
3762018
The Danish National Diabetes Register: trends in incidence, prevalence and mortality
B Carstensen, JK Kristensen, P Ottosen, K Borch-Johnsen
Diabetologia 51 (12), 2187-2196, 2008
3732008
The E23K variant of Kir6. 2 associates with impaired post-OGTT serum insulin response and increased risk of type 2 diabetes
EMD Nielsen, L Hansen, B Carstensen, SM Echwald, T Drivsholm, ...
Diabetes 52 (2), 573-577, 2003
3432003
Cardiovascular mortality and morbidity in patients with type 2 diabetes following initiation of sodium-glucose co-transporter-2 inhibitors versus other glucose-lowering drugs …
KI Birkeland, ME Jørgensen, B Carstensen, F Persson, HL Gulseth, ...
The lancet Diabetes & endocrinology 5 (9), 709-717, 2017
3262017
Additive effect of ACE inhibition and angiotensin II receptor blockade in type I diabetic patients with diabetic nephropathy
P Jacobsen, S Andersen, BR Jensen, HH Parving
Journal of the American Society of Nephrology 14 (4), 992-999, 2003
2842003
Diabetes and cancer (1): evaluating the temporal relationship between type 2 diabetes and cancer incidence
JA Johnson, B Carstensen, D Witte, SL Bowker, L Lipscombe, ...
Diabetologia 55 (6), 1607-1618, 2012
2442012
Dietary glycemic index, glycemic load, fiber, simple sugars, and insulin resistance: the Inter99 study
C Lau, K Færch, C GLumer, I Tetens, O Pedersen, B Carstensen, ...
Diabetes care 28 (6), 1397-1403, 2005
2412005
Dietary glycemic index, glycemic load, fiber, simple sugars, and insulin resistance: the Inter99 study
C Lau, K Færch, C GLumer, I Tetens, O Pedersen, B Carstensen, ...
Diabetes care 28 (6), 1397-1403, 2005
2402005
Dietary glycemic index, glycemic load, fiber, simple sugars, and insulin resistance: the Inter99 study
C Lau, K Færch, C GLumer, I Tetens, O Pedersen, B Carstensen, ...
Diabetes care 28 (6), 1397-1403, 2005
2402005
Dietary glycemic index, glycemic load, fiber, simple sugars, and insulin resistance: the Inter99 study
C Lau, K Færch, C GLumer, I Tetens, O Pedersen, B Carstensen, ...
Diabetes care 28 (6), 1397-1403, 2005
2402005
The Nottingham prognostic index applied to 9,149 patients from the studies of the Danish Breast Cancer Cooperative Group (DBCG)
I Balslev, CK Axelsson, K Zedeler, BB Rasmussen, B Carstensen, ...
Breast cancer research and treatment 32 (3), 281-290, 1994
2391994
Dapagliflozin is associated with lower risk of cardiovascular events and all‐cause mortality in people with type 2 diabetes (CVD‐REAL Nordic) when compared with dipeptidyl …
F Persson, T Nyström, ME Jørgensen, B Carstensen, HL Gulseth, ...
Diabetes, Obesity and Metabolism 20 (2), 344-351, 2018
215*2018
Dapagliflozin is associated with lower risk of cardiovascular events and all‐cause mortality in people with type 2 diabetes (CVD‐REAL Nordic) when compared with dipeptidyl …
F Persson, T Nyström, ME Jørgensen, B Carstensen, HL Gulseth, ...
Diabetes, Obesity and Metabolism 20 (2), 344-351, 2018
215*2018
Age, body mass index and Type 2 diabetes-associations modified by ethnicity.
T Nakagami, Q Qiao, B Carstensen, C Nhr-Hansen, G Hu, J Tuomilehto, ...
Diabetologia 46 (8), 1063-1070, 2003
2092003
Epi: a package for statistical analysis in epidemiology
B Carstensen, M Plummer, E Laara, M Hills
R package version 1 (8), 2008
1972008
Studies of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-γ2 (PPAR-γ2) gene in relation to insulin sensitivity among glucose tolerant Caucasians
J Ek, G Andersen, SA Urhammer, L Hansen, B Carstensen, ...
Diabetologia 44 (9), 1170-1176, 2001
1962001
Systemet kan ikke foretage handlingen nu. Prøv igen senere.
Artikler 1–20